Aflac clears an all-time high, shares trade near record levels
25.06.2026 - 19:14:10 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-25, 19:10.
Aflac Inc. (US0010551028) has pushed its New York-listed shares to a new all-time high this week. According to Investing.com, the stock reached around 119.85 dollars, marginally above the previous 52-week peak of about 119.81 dollars.Investing.com report on Aflac's record high
Record level on the NYSE
The Aflac shares trade on the NYSE under the ticker AFL, with recent intraday ranges between roughly 116.90 and 120.23 dollars.Robinhood price overview for AFL Investing.com highlights that the stock touched about 119.89 dollars, clearing the prior 52-week high and marking a new record area for the insurer.Investing.com analysis of the all-time high
Analyst consensus stays cautious
Despite the strong share performance, the analyst view on Aflac remains muted. Public.com cites 11 Wall Street analysts with a consensus rating of Hold for AFL, with around 55 percent recommending to hold, 18 percent at Buy and 27 percent at Sell.Public.com summary of Aflac analyst ratings The same compilation shows an average price target of about 112.09 dollars, modestly below the recent trading band.
Background and price data on Aflac
Key figures, past news and chart data on Aflac help investors understand how the shares reached their recent record level on the NYSE.
Dividend and earnings track record
The insurer's fundamental profile underpins the robust share trend. Investing.com notes that Aflac has increased its dividend for 42 consecutive years, reflecting a consistent capital-return policy for investors.Investing.com comments on Aflac's dividend history Robinhood data shows a current dividend yield around 2 percent and a price-earnings multiple near 13.4, placing the shares in a moderate valuation band compared with larger U.S. insurers.Robinhood valuation snapshot for AFL
Operations and strategic initiatives
Operationally, Aflac reported strong revenue in its first-quarter 2026 update, with approximately 4.35 billion dollars in revenue versus expectations around 4.18 billion dollars, according to Investing.com.Investing.com coverage of Aflac's Q1 results The same report notes that adjusted earnings per share came in slightly below consensus, leading to a mixed but overall resilient picture for the quarter.
The product behind the stock
Aflac generates most of its revenue from supplemental health and life insurance policies, including well-known cancer and accident coverage products in the United States and Japan.Aflac corporate overview and product information The business model relies on employer-sponsored and individual policies that complement primary health insurance, with predictable premium streams and long-term customer relationships.
Where the shares trade today
The Aflac shares (US0010551028) trade on 2026-06-25 on the NYSE at around 118.40 dollars, based on Robinhood quote data.Latest AFL quote and trading range
Key data on the Aflac shares
- Company: Aflac Incorporated
- ISIN: US0010551028
- WKN: 853081
- Ticker: AFL
- Trading venue: NYSE
- Price (as of 2026-06-25, 19:00): 118.40 USD
- Market cap: 60.26 billion USD (as of 2026-06-25)
- Sector / industry: Financials / Insurance
- Index membership: S&P 500
- Next earnings date: 2026-07-31
This article is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell any securities. All data were obtained from sources considered reliable at the time of publication, but cannot be guaranteed. Investors should perform their own research and consider consulting a qualified financial advisor before making investment decisions.
